In a world where joint health issues have become increasingly common, individuals struggle with stiffness, discomfort, and ...

In the second world war, the physician Henry Beecher observed that some of his soldier patients, despite being injured on the ...

A team of researchers at the Medical University of South Carolina has discovered that a commonly used drug, N-acetylcysteine (NAC), could help reduce pain after surgery.

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

Red light therapy is increasingly viewed as a promising treatment for wrinkles, acne, psoriasis, scars and sun-damaged skin, and as a supportive therapy for some kinds of cancer. But does red light ...

Ubrelvy and Nurtec are prescription medications taken to treat migraines. Though they share similarities, Ubrelvy is for acute treatment, while Nurtec can be taken for immediate symptom relief.

Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...

Most states allow some form of "medical marijuana." It is especially popular with pain patients, many of whom do not have ...

While New Orleans prepares for the excitement of the big game, it’s important to remember that sports injuries aren’t limited to the professionals. High school athletes, weekend warriors, and generall ...

The Food and Drug Administration has approved Journavx (suzetrigine) for the treatment of moderate to severe acute pain in adults.

The FDA has approved a new non-opioid prescription medication, Journavx for adults with moderate to severe acute pain.

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...